BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 10442092)

  • 1. The modular nature of apoptotic signaling proteins.
    Hofmann K
    Cell Mol Life Sci; 1999 Jul; 55(8-9):1113-28. PubMed ID: 10442092
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fas-associated death domain protein interleukin-1beta-converting enzyme 2 (FLICE2), an ICE/Ced-3 homologue, is proximally involved in CD95- and p55-mediated death signaling.
    Vincenz C; Dixit VM
    J Biol Chem; 1997 Mar; 272(10):6578-83. PubMed ID: 9045686
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel family of viral death effector domain-containing molecules that inhibit both CD-95- and tumor necrosis factor receptor-1-induced apoptosis.
    Hu S; Vincenz C; Buller M; Dixit VM
    J Biol Chem; 1997 Apr; 272(15):9621-4. PubMed ID: 9092488
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fas-associated death domain protein and caspase-8 are not recruited to the tumor necrosis factor receptor 1 signaling complex during tumor necrosis factor-induced apoptosis.
    Harper N; Hughes M; MacFarlane M; Cohen GM
    J Biol Chem; 2003 Jul; 278(28):25534-41. PubMed ID: 12721308
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Apoptosis control by death and decoy receptors.
    Ashkenazi A; Dixit VM
    Curr Opin Cell Biol; 1999 Apr; 11(2):255-60. PubMed ID: 10209153
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Involvement of MACH, a novel MORT1/FADD-interacting protease, in Fas/APO-1- and TNF receptor-induced cell death.
    Boldin MP; Goncharov TM; Goltsev YV; Wallach D
    Cell; 1996 Jun; 85(6):803-15. PubMed ID: 8681376
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A potential mechanism of "cross-talk" between the p55 tumor necrosis factor receptor and Fas/APO1: proteins binding to the death domains of the two receptors also bind to each other.
    Varfolomeev EE; Boldin MP; Goncharov TM; Wallach D
    J Exp Med; 1996 Mar; 183(3):1271-5. PubMed ID: 8642271
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The kiss of death: promises and failures of death receptors and ligands in cancer therapy.
    Daniel PT; Wieder T; Sturm I; Schulze-Osthoff K
    Leukemia; 2001 Jul; 15(7):1022-32. PubMed ID: 11455969
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Direct binding of Fas-associated death domain (FADD) to the tumor necrosis factor-related apoptosis-inducing ligand receptor DR5 is regulated by the death effector domain of FADD.
    Thomas LR; Henson A; Reed JC; Salsbury FR; Thorburn A
    J Biol Chem; 2004 Jul; 279(31):32780-5. PubMed ID: 15173180
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Casper is a FADD- and caspase-related inducer of apoptosis.
    Shu HB; Halpin DR; Goeddel DV
    Immunity; 1997 Jun; 6(6):751-63. PubMed ID: 9208847
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Apo2L/TRAIL-dependent recruitment of endogenous FADD and caspase-8 to death receptors 4 and 5.
    Kischkel FC; Lawrence DA; Chuntharapai A; Schow P; Kim KJ; Ashkenazi A
    Immunity; 2000 Jun; 12(6):611-20. PubMed ID: 10894161
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Death-inducing functions of ligands of the tumor necrosis factor family: a Sanhedrin verdict.
    Wallach D; Kovalenko AV; Varfolomeev EE; Boldin MP
    Curr Opin Immunol; 1998 Jun; 10(3):279-88. PubMed ID: 9638364
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Signal transduction by DR3, a death domain-containing receptor related to TNFR-1 and CD95.
    Chinnaiyan AM; O'Rourke K; Yu GL; Lyons RH; Garg M; Duan DR; Xing L; Gentz R; Ni J; Dixit VM
    Science; 1996 Nov; 274(5289):990-2. PubMed ID: 8875942
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulation of life and death by the TNF receptor superfamily.
    Baker SJ; Reddy EP
    Oncogene; 1998 Dec; 17(25):3261-70. PubMed ID: 9916988
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Apoptotic activity of REAPER is distinct from signaling by the tumor necrosis factor receptor 1 death domain.
    Chen P; Lee P; Otto L; Abrams J
    J Biol Chem; 1996 Oct; 271(42):25735-7. PubMed ID: 8824198
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Constitutive caspase activation and impaired death-inducing signaling complex formation in CD95-resistant, long-term activated, antigen-specific T cells.
    Strauss G; Knape I; Melzner I; Debatin KM
    J Immunol; 2003 Aug; 171(3):1172-82. PubMed ID: 12874203
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distinct adapter proteins mediate acid versus neutral sphingomyelinase activation through the p55 receptor for tumor necrosis factor.
    Adam-Klages S; Schwandner R; Adam D; Kreder D; Bernardo K; Krönke M
    J Leukoc Biol; 1998 Jun; 63(6):678-82. PubMed ID: 9620659
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevention of constitutive TNF receptor 1 signaling by silencer of death domains.
    Jiang Y; Woronicz JD; Liu W; Goeddel DV
    Science; 1999 Jan; 283(5401):543-6. PubMed ID: 9915703
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The C-terminal tails of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) and Fas receptors have opposing functions in Fas-associated death domain (FADD) recruitment and can regulate agonist-specific mechanisms of receptor activation.
    Thomas LR; Johnson RL; Reed JC; Thorburn A
    J Biol Chem; 2004 Dec; 279(50):52479-86. PubMed ID: 15452120
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Death receptor-induced activation of initiator caspase 8 is antagonized by serine/threonine kinase PAK4.
    Gnesutta N; Minden A
    Mol Cell Biol; 2003 Nov; 23(21):7838-48. PubMed ID: 14560027
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.